Dr. Gibson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave.
Boston, MA 02115Phone+1 617-632-3779- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016- Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2012
Yale School of MedicineClass of 2009
Certifications & Licensure
MA State Medical License 2011 - 2025
CT State Medical License 2022 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer.Morganti, S., Gibson, C., Jin, Q., Santos, K., Patel, A., Wilson, A., Merrill, M., Vincuilla, J., Stokes, S., Lipsyc-Sharf, M., Parker, T., King, T., Mittendorf, E., C...> ;Journal of Clinical Oncology. 2024 Jan 8
- Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis.Patel, A. A., Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle D Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, ...> ;Blood Cancer Discovery. 2023 Dec 27
- 1 citationsAssociation of Somatic TET2 Mutations With Giant Cell Arteritis.Michelle L Robinette, Lachelle D Weeks, Ryan J Kramer, Mridul Agrawal, Christopher J Gibson, Zhi Yu, Aswin Sekar, Arnav Mehta, Abhishek Niroula, Jared T Brown, Gregory...> ;Arthritis & Rheumatology. 2024 Mar 1
- Join now to see all
Abstracts/Posters
- Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloi...Christopher J. Gibson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of ResponseChristopher J. Gibson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant AbstractChristopher J. Gibson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Hospital Affiliations
Brigham and Women's HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
